Litcius/Paper detail

Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer’s Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota

Changjiang Li, Na Wang, Guodong Zheng, Licong Yang

2021ACS Applied Materials & Interfaces163 citationsDOI

Abstract

. Thus, we anticipate that Res-selenium-peptide nanocomposites will offer a new potential strategy for the treatment of AD.

Topics & Concepts

ResveratrolSeleniumNanocompositeMaterials sciencePathogenesisOral administrationPeptideGut floraNanotechnologyMicrobiologyPharmacologyBiochemistryMedicineBiologyImmunologyMetallurgyTryptophan and brain disordersAlzheimer's disease research and treatmentsBiochemical effects in animals
Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer’s Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota | Litcius